A Sex-Specific Comparative Analysis of Oxidative Stress Biomarkers Predicting the Risk of Cardiovascular Events and All-Cause Mortality in the General Population: A Prospective Cohort Study

Oxidative stress plays a pivotal role in cardiovascular (CV) disease, but current biomarkers used to predict CV events are still insufficient. In this study, we comparatively assessed the utility of redox-related biomarkers in predicting the risk of CV events and all-cause mortality in male and female subjects from the general population. Subjects (n = 5955) of the Prevention of REnal and Vascular ENd-stage Disease (PREVEND) population-based cohort study were included. Blood homocysteine, gamma-GT, HDL cholesterol, bilirubin and protein-adjusted free thiol (R-SH, sulfhydryl groups) levels were quantified at baseline and were prospectively analyzed in association with the risk of CV events and all-cause mortality. After adjustment for potentially confounding factors, protein-adjusted R-SH and homocysteine levels were significantly associated with the risk of CV events in men (HR 0.63 [0.40–0.99], p = 0.045 and HR 1.58 [1.20–2.08], p = 0.001, respectively). Protein-adjusted R-SH and HDL cholesterol levels were significantly associated with the risk of all-cause mortality in men (HR 0.52 [0.32–0.85], p = 0.009 and HR 0.90 [0.85–0.94], p < 0.001, respectively), while the same was observed for bilirubin and homocysteine levels in women (HR 0.68 [0.48–0.98], p = 0.040 and HR 2.30 [1.14–3.76], p < 0.001, respectively). Lower levels of protein-adjusted R-SH were robustly associated with an increased risk of CV events and all-cause mortality in men. Our results highlight the value of R-SH levels in cardiovascular risk assessment and their potential significance as being amenable to therapeutic intervention, while reaffirming the importance of other oxidative stress-related biomarkers, such as homocysteine, HDL cholesterol and bilirubin.

[1]  Fawei Yuan,et al.  Homocysteine and the Mortality of Critically Ill Patients: A Meta-Analysis. , 2022, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[2]  H. van Goor,et al.  Acute serum free thiols: a potentially modifiable biomarker of oxidative stress following traumatic brain injury , 2022, Journal of Neurology.

[3]  Lyanne M. Kieneker,et al.  Systemic oxidative stress associates with new-onset hypertension in the general population. , 2022, Free radical biology & medicine.

[4]  Lyanne M. Kieneker,et al.  Serum free sulfhydryl status associates with new-onset chronic kidney disease in the general population , 2021, Redox biology.

[5]  P. V. D. van der Voort,et al.  Mild Coronavirus Disease 2019 (COVID-19) Is Marked by Systemic Oxidative Stress: A Pilot Study , 2021, Antioxidants.

[6]  E. Tapper,et al.  Gamma‐Glutamyl Transferase (γ‐GT) – an old dog with new tricks? , 2021, Liver international : official journal of the International Association for the Study of the Liver.

[7]  S. Bakker,et al.  High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events , 2021, Circulation.

[8]  Lyanne M. Kieneker,et al.  Systemic Oxidative Stress, Aging and the Risk of Cardiovascular Events in the General Female Population , 2021, Frontiers in Cardiovascular Medicine.

[9]  S. Vatner,et al.  Healthful aging mediated by inhibition of oxidative stress , 2020, Ageing Research Reviews.

[10]  Bao Huang,et al.  Homocysteine Induces Oxidative Stress and Ferroptosis of Nucleus Pulposus Via Enhancing Methylation of GPX4. , 2020, Free radical biology & medicine.

[11]  K. Faber,et al.  Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease. , 2020, Trends in molecular medicine.

[12]  S. Bakker,et al.  Oxidative stress is associated with suspected non‐alcoholic fatty liver disease and all‐cause mortality in the general population , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[13]  Lyanne M. Kieneker,et al.  Serum free thiols predict cardiovascular events and all-cause mortality in the general population: a prospective cohort study , 2020, BMC Medicine.

[14]  K. Janda,et al.  Reactive oxygen species - sources, functions, oxidative damage. , 2020, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[15]  G. Zhong,et al.  HDL-C is associated with mortality from all causes, cardiovascular disease and cancer in a J-shaped dose-response fashion: a pooled analysis of 37 prospective cohort studies , 2020, European journal of preventive cardiology.

[16]  Martin Feelisch,et al.  The Redox architecture of physiological function , 2019, Current opinion in physiology.

[17]  M. Woodward Cardiovascular Disease and the Female Disadvantage , 2019, International journal of environmental research and public health.

[18]  M. Bobák,et al.  Association between plasma bilirubin and mortality. , 2019, Annals of hepatology.

[19]  E. Stamatakis,et al.  High-Density Lipoprotein Cholesterol and Mortality: Too Much of a Good Thing? , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[20]  M. Tenkorang,et al.  Sex-related differences in oxidative stress and neurodegeneration , 2017, Steroids.

[21]  D. Wink,et al.  The Reactive Species Interactome: Evolutionary Emergence, Biological Significance, and Opportunities for Redox Metabolomics and Personalized Medicine , 2017, Antioxidants & redox signaling.

[22]  B. Nordestgaard,et al.  Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies , 2017, European heart journal.

[23]  A. Berghold,et al.  Serum Concentration of HDL Particles Predicts Mortality in Acute Heart Failure Patients , 2017, Scientific Reports.

[24]  Dajiang J. Liu,et al.  Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease , 2016, Science.

[25]  H. Brenner,et al.  Evidence for the free radical/oxidative stress theory of ageing from the CHANCES consortium: a meta-analysis of individual participant data , 2015, BMC Medicine.

[26]  S. Seneff,et al.  Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk , 2015, Disease markers.

[27]  R. Chowdhury,et al.  Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[28]  S. Bakker,et al.  Circulating gamma glutamyltransferase and prediction of cardiovascular disease. , 2015, Atherosclerosis.

[29]  H. Sies,et al.  Oxidative stress: a concept in redox biology and medicine , 2015, Redox biology.

[30]  Darrel P Francis,et al.  Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients , 2014, BMJ : British Medical Journal.

[31]  P. van der Harst,et al.  Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study , 2014, Diabetologia.

[32]  C. Shoulders,et al.  Evidence of a Polygenic Origin of Extreme High-Density Lipoprotein Cholesterol Levels , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[33]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[34]  Dean P. Jones,et al.  Cysteine/cystine redox signaling in cardiovascular disease. , 2011, Free radical biology & medicine.

[35]  Ingrid Zegers,et al.  First certified reference material for cystatin C in human serum ERM-DA471/IFCC , 2010, Clinical chemistry and laboratory medicine.

[36]  D. Cucinotta,et al.  Menopause modulates homocysteine levels in diabetic and non-diabetic women , 2008, Journal of endocrinological investigation.

[37]  R. Schnabel,et al.  Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. , 2005, Journal of the American College of Cardiology.

[38]  D. Kalra Homocysteine and cardiovascular disease , 2004, Current atherosclerosis reports.

[39]  N. D. De Santo,et al.  Homocysteine and oxidative stress , 2003, Amino Acids.

[40]  A. Myers,et al.  Estrogen and homocysteine. , 2002, Cardiovascular research.

[41]  D. Grobbee,et al.  Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity , 2001, Journal of internal medicine.

[42]  B. Horne,et al.  Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease , 2000, Circulation.

[43]  A. Hofman,et al.  Increased plasma homocysteine after menopause. , 2000, Atherosclerosis.

[44]  P. Dennery,et al.  Antioxidant and Cytotoxic Effects of Bilirubin on Neonatal Erythrocytes , 1999, Pediatric Research.

[45]  I. Rosenberg,et al.  Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. , 1999, The American journal of clinical nutrition.

[46]  M. Stanton,et al.  Homocysteine and cardiovascular disease , 2011 .

[47]  C. Cross,et al.  Antioxidant protection against hypochlorous acid in human plasma. , 1993, The Journal of laboratory and clinical medicine.

[48]  G. Ellman,et al.  Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.

[49]  A. Kastrati,et al.  Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[50]  V. Miller,et al.  Sex-Specific Physiology and Cardiovascular Disease. , 2018, Advances in experimental medicine and biology.

[51]  F. Violi,et al.  Oxidative stress and cardiovascular disease: new insights. , 2018, Kardiologia polska.

[52]  S. Howlett,et al.  Differences in Cardiovascular Aging in Men and Women. , 2018, Advances in experimental medicine and biology.

[53]  J. Mason,et al.  Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. , 2010, Preventive cardiology.

[54]  K. Rye,et al.  High-density lipoproteins, inflammation and oxidative stress. , 2009, Clinical science.

[55]  G. Braemer International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.